These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
498 related articles for article (PubMed ID: 30503931)
1. MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma. Bi JG; Zheng JF; Li Q; Bao SY; Yu XF; Xu P; Liao CX Int J Biochem Cell Biol; 2019 Jan; 106():107-116. PubMed ID: 30503931 [TBL] [Abstract][Full Text] [Related]
2. High glucose down-regulates microRNA-181a-5p to increase pro-fibrotic gene expression by targeting early growth response factor 1 in HK-2 cells. Xu P; Guan MP; Bi JG; Wang D; Zheng ZJ; Xue YM Cell Signal; 2017 Feb; 31():96-104. PubMed ID: 28077323 [TBL] [Abstract][Full Text] [Related]
3. miR-4458 inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing the TGF-β signaling pathway via targeting TGFBR1. Zhang Y; Shi K; Liu H; Chen W; Luo Y; Wei X; Wu Z Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):554-562. PubMed ID: 32324847 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma. Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF. Long J; Jiang C; Liu B; Fang S; Kuang M Tumour Biol; 2016 May; 37(5):5821-8. PubMed ID: 26581909 [TBL] [Abstract][Full Text] [Related]
6. The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma. Tang YH; He GL; Huang SZ; Zhong KB; Liao H; Cai L; Gao Y; Peng ZW; Fu SJ Mol Oncol; 2019 May; 13(5):1296-1310. PubMed ID: 30943320 [TBL] [Abstract][Full Text] [Related]
7. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation. Zhang Y; Wen DY; Zhang R; Huang JC; Lin P; Ren FH; Wang X; He Y; Yang H; Chen G; Luo DZ Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928 [TBL] [Abstract][Full Text] [Related]
8. MiR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met. Korhan P; Erdal E; Atabey N Biochem Biophys Res Commun; 2014 Aug; 450(4):1304-12. PubMed ID: 25058462 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Zhou SJ; Liu FY; Zhang AH; Liang HF; Wang Y; Ma R; Jiang YH; Sun NF Br J Cancer; 2017 Jul; 117(2):233-244. PubMed ID: 28588321 [TBL] [Abstract][Full Text] [Related]
10. MiR-369-5p inhibits the proliferation and migration of hepatocellular carcinoma cells by down-regulating HOXA13 expression. Qian X; Wang Y; Hu W; Xu X; Gao L; Meng Y; Yan J Tissue Cell; 2022 Feb; 74():101721. PubMed ID: 34979376 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-181a-5p enhances cell proliferation in medullary thymic epithelial cells via regulating TGF-β signaling. Guo D; Ye Y; Qi J; Zhang L; Xu L; Tan X; Yu X; Liu Q; Liu J; Zhang Y; Ma Y; Li Y Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):840-9. PubMed ID: 27411504 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1. Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB. Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689 [TBL] [Abstract][Full Text] [Related]
14. TGF-β1-Induced LINC01094 promotes epithelial-mesenchymal transition in hepatocellular carcinoma through the miR-122-5p/TGFBR2-SAMD2-SMAD3 Axis. Yang X; Xu C; Liu C; Wu X; Chen X; Hou J; Wang L Funct Integr Genomics; 2024 Jul; 24(4):123. PubMed ID: 38992207 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29. Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939 [TBL] [Abstract][Full Text] [Related]
16. Galangin suppresses HepG2 cell proliferation by activating the TGF-β receptor/Smad pathway. Wang Y; Wu J; Lin B; Li X; Zhang H; Ding H; Chen X; Lan L; Luo H Toxicology; 2014 Dec; 326():9-17. PubMed ID: 25268046 [TBL] [Abstract][Full Text] [Related]
17. miR-494 induces EndMT and promotes the development of HCC (Hepatocellular Carcinoma) by targeting SIRT3/TGF-β/SMAD signaling pathway. Zhang J; Zhu Y; Hu L; Yan F; Chen J Sci Rep; 2019 May; 9(1):7213. PubMed ID: 31076630 [TBL] [Abstract][Full Text] [Related]
18. MiR-133a acts as an anti-oncogene in Hepatocellular carcinoma by inhibiting FOSL2 through TGF-β/Smad3 signaling pathway. Sun L; Guo Z; Sun J; Li J; Dong Z; Zhang Y; Chen J; Kan Q; Yu Z Biomed Pharmacother; 2018 Nov; 107():168-176. PubMed ID: 30086463 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells. Feili X; Wu S; Ye W; Tu J; Lou L Cell Biol Int; 2018 Sep; 42(10):1370-1376. PubMed ID: 29957876 [TBL] [Abstract][Full Text] [Related]
20. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway. Yu J; Yang M; Zhou B; Luo J; Zhang Z; Zhang W; Yan Z Clin Sci (Lond); 2019 Jul; 133(13):1487-1503. PubMed ID: 31278132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]